Anti-C1q antibodies as a marker for disease activity in systemic lupus erythematosus and lupus nephritis

Study for The Relationship between Lupus Nephritis and Anti-C1q Antibodies

Study of Anti-nucleosome Antibodies as A Predictor of Early Renal Affection in Systemic Lupus Erythematosus Patients

Anti-C1q antibodies as a specific serological marker In patients with active lupus nephritis

Anti-Nucleosome Antibody as a Marker of Systemic Lupus Erythematosus Activity

Utility of Serum Anti-C1q Autoantibodies as a Biomarker of Lupus Nephritis in Children

Role of Tenascin-C in Systemic Lupus Erythematosus and Its Association with Disease Activity: Review Article

Beta 2 Microglobulin and Cystatin C in Systemic Lupus Erythematosus Patients: Correlation with Disease Activity

Clinical importance of C1q antibodies in systemic lupus patients with and without nephritis

Study of Some Biomarkers Changes in Patients with Lupus Nephritis and Their Correlation with Disease Activity and Progression